Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

2nd International Conference on Drug Discovery 2026

industry leaders, and academicians from around the world to explore groundbreaking innovations in drug research, pharmaceutical sciences, and biotechnology. The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis...

Digi-Tech Pharma & AI Conference 2026

The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...

2nd Annual MaxPotent Pharma Summit 2026

leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). 2nd...

8th International Conference on PharmScience Research & Development 2026

event, organized by United Scientific Group (USG), a non-profit organization, is dedicated to advancing the field of pharmaceutical science for medical and biophysical chemists across the pharmaceutical, biotech, and academic sectors. The...

SECuRE trial update: Another participant with negative PSMA PET and undetectable PSA

Clarity Pharmaceuticals a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that yet another participant with mCRPC in the...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

choice for biopharma innovators, market access leaders, and brand strategists. Trusted by all 30 of the world's top pharmaceutical companies, and leading biotechs, we specialise in transforming complex data into clear, actionable strategies that...

New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

and corticosteroid-free remission generally maintained through Week. About Celltrion Celltrion is a leading biopharmaceutical company that specializes in researching, developing, manufacturing, marketing and sales of innovative therapeutics that...

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on targeting rare, neglected, and poverty-related diseases. For more information...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

regulator, capable of reprogramming gene expression in tumor cells. This discovery opens new horizons in oncology and pharmaceutical development: Deuterium modulation emerges as a novel therapeutic target—not merely a passive change in water...

FDA Grants KORU Medical Systems 510(k) Clearance for RYSTIGGO® Delivery via FreedomEDGE® Infusion System

professional. Through its Pharma Service and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of...

Tonix Pharmaceuticals presented Phase 3 RESILIENT data on TONMYA™ (cyclobenzaprine HCl sublingual tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

Tonix Pharmaceuticals Holding Corp. a fully integrated, commercial biotechnology company, presented data on TONMYA™, which was investigated as TNX-102 SL, at the 2026 Non-Opioid Pain Therapeutics Summit, on January 29, 2026, in Boston,...

China approves Libevitug, first-in-class therapy for hepatitis D

CDE, NMPA (2023) and the U.S. FDA (2024). About Huahui Health Founded in Beijing in 2015, Huahui Health is a biopharmaceutical company dedicated to developing first-in-class and best-in-class therapies, with a strategic focus on viral hepatitis,...

The Digital Pharma Advances Conference 2026

Conference returns to the Grand Connaught Rooms, London, uniting 35+ senior executives from 13 of the world's top 20 pharmaceutical companies. The 14th Annual Digital Pharma Advances Conference returns to the Grand Connaught Rooms, London, uniting...

Correction — Privo Technologies

potential to reduce cancer recurrence. About Privo Technologies, Inc. Privo Technologies is a late-stage clinical biopharmaceutical company developing localized therapies for solid tumors using its proprietary nanoengineered delivery platform,...

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

In a move set to strengthen the nation's approach to pharmaceutical waste management, PureWay and the Pharmaceutical Product Stewardship Work Group (PPSWG) announced a strategic collaboration to improve safety, compliance, and sustainability in...

Clover Begins Phase 2 Clinical Evaluation of a Combination Respiratory Vaccine Targeting RSV, hMPV, and ± PIV3

Clover Biopharmaceuticals, Ltd. a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. Announced that enrollment of the first participants has...

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

Shanghai Ark Biopharmaceutical Co., Ltd. announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and Dexmethylphenidate Hydrochloride Capsules (Aizhida) for...

Novotech Appoints Anand Tharmaratnam as Chief Executive Officer

clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. With a global footprint that includes 30+ offices across the...

RoslinCT and BOOST Pharma Form Strategic Manufacturing Partnership to Advance Cell Therapy for Osteogenesis Imperfecta

with BOOST Pharma’s clinical and future commercial goals. About BOOST Pharma ApS BOOST Pharma is a clinical-stage biopharmaceutical company focused on the development of novel cell therapy treatments. The company is currently developing a...

In Europe, Samsung Bioepis begins the commercialization of BYOOVIZ®, a biosimilar to Lucentis (Ranibizumab)

OBODENCE (denosumab) and XBRYK (denosumab) in Europe, we will continue on our journey to become a fully integrated biopharmaceutical company with end-to-end capabilities from development to commercialization,” said Antonio Rito, Vice President and...